NEW YORK (GenomeWeb News) - Vermillion said yesterday that it has regained compliance for listing on the Nasdaq Stock Market by retaining a market value of $35 million for a period of ten consecutive business days.
 
In August, Nasdaq notified the company, which was called Ciphergen at the time, that it was out of compliance with Nasdaq Marketplace Rule 4310(c)(3) due to insufficient market value.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.